SHUKLA SANJAY (President and CEO) exercised options at ATYR PHARMA INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/4/2025ACC: 0000950170-25-013891
Officer· President and CEO
Since Feb 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
10.38K acquired · 10.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.38K
Price / share
—
Trade value
—
% of position
7.6%
2/3/2025
136.55K→146.92K
Total
Net shares
+10.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2025 | M · Option Exercise | +10.38K | — | — | 7.6% | 136.55K | 146.92K |
| Total | +10.38K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
10.38K shares
Shares
−10.38K
Strike price
Held after
10.38K
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock10.38K shares | 2/3/2025 | M · Option Exercise | −10.38K | — | 10.38K |